Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-25

FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s supplemental application for the generic antidepressant citalopram.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM)